Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2010
09/29/2010CN101843599A Oral cephalosporin ester capsule
09/29/2010CN101843598A Preparation method of felodipine sustained release tablets
09/29/2010CN101843596A Methadone hydrochloride dispersible tablet and preparation method thereof
09/29/2010CN101843595A Formula of oral mucosa absorbing dosage form of medicines of polypeptides and proteins, and preparation method and application thereof
09/29/2010CN101843594A Alprostadil freeze-dried emulsion for injection and preparation method thereof
09/29/2010CN101843593A Novel vecuronium bromide freeze-dried preparation and preparation method thereof
09/29/2010CN101843592A Preparation method of decitabine freeze-dried powder injection
09/29/2010CN101843591A 1'-acetoxyl chavicol acetate naonparticle
09/29/2010CN101843590A Extended release venlafaxine formulation
09/29/2010CN101843586A Water-soluble micro powder containing florfenicol and preparation method thereof
09/29/2010CN101843585A Method for preparing whole peptidoglycan magnetic liposome
09/29/2010CN101843584A Composite of all-trans-retinoic acid and liposome and application thereof
09/29/2010CN101843583A Quantum dot iodized oil dispersion and preparation method and use thereof
09/29/2010CN101843582A Taxol nanosuspension and preparation method thereof
09/29/2010CN101843580A Preparation method of pidotimod injection preparation
09/29/2010CN101843579A 5-hydroxymethyl Tolterodine gel preparation and preparation method thereof
09/29/2010CN101843578A Nanofiber membrane carrying anti-tumor photosensitizer and preparation method thereof
09/29/2010CN101843577A Coating implant using zein as skeleton material and preparation method
09/29/2010CN101590061B Medicinal composition of cefotetan disodium
09/29/2010CN101518516B Sodium riboflavin phosphate lyophilized powder for injection and preparation method thereof
09/29/2010CN101450035B Double sustained release biological agent for tumor local ablation therapy
09/29/2010CN101427998B Astragalus polysaccharide calcium phosphate nano-paclitaxel composite injection, and preparation method
09/29/2010CN101406455B Strychnine composite phospholipid liposome, and preparation method thereof and use in pharmacy
09/29/2010CN101322692B Hydrochloric clindamycin nano granule formulation for injections
09/29/2010CN101314041B Medicine carrying system of polymer micelle and preparation method thereof
09/29/2010CN101301293B Acidum folicum effervescent tablet and preparation thereof
09/29/2010CN101297974B Pegylated glycosides of aerial parts of epimedium, and preparation and use thereof
09/29/2010CN101269058B Spraying agent containing diclofenac acid and uses thereof
09/29/2010CN101252909B Prolonged release formulations comprising anastrozole
09/29/2010CN101249131B Gynostemma pentaphylla effective ingredient extract
09/29/2010CN101244225B Externally used medical ointment for regain consciousness, refrigerating and relieving summer-heat, and preparation thereof
09/29/2010CN101244204B Suppository for treating hemorrhoid
09/29/2010CN101244068B Hemsleyadin sustained-release preparation
09/29/2010CN101234204B High molecule bonding adriamycin medicine, nano capsule and preparation thereof
09/29/2010CN101234168B Compound angelica sinensis preparations and preparation and application
09/29/2010CN101214344B Chinese medicine preparation for treating coronary disease and stenocardia and preparation thereof
09/29/2010CN101209256B Polydatin medicinal composition containing polyvinyl pyrrolidone
09/29/2010CN101194916B Oral cavity rapid release preparation and method for preparing the same
09/29/2010CN101147800B Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method
09/29/2010CN101138554B Effervescence dispersible tablet
09/29/2010CN101138544B Diclofenac or the salt partial film forming gel composition and uses thereof
09/29/2010CN101120930B Omeprazole composition and preparing process thereof
09/29/2010CN101116665B Malaria-resisting arteannuin naphthoquine compound composition
09/29/2010CN101112405B Drug for curing coronary disease and method for preparing the same
09/29/2010CN101112360B Allicin fatty milk injection and preparation technics thereof
09/29/2010CN101111306B Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof
09/29/2010CN101103964B Sustained-release preparation containing felodipine and preparation method thereof
09/29/2010CN101081203B Hydrogel, alcogel pharmaceutical uses
09/29/2010CN101049466B Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method
09/29/2010CN101036719B Sirup agent for curing cough for children and the preparing method
09/29/2010CN101024085B Precursor medicine for target treatment of colon cancer and preparing method
09/29/2010CN101011534B Chinese medicine preparation for treating ulcerative proctitis and its preparation process
09/29/2010CN101011403B Pharmaceutical composition of adefovir dipivoxil and its preparation method
09/28/2010US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity
09/28/2010US7803911 preparing a stable dried composition of blood factor product containing a stabilizing amount of trehalose in the absence of a stabilizing amount of albumin
09/28/2010US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
09/28/2010US7803791 biological conjugate drug comprising enzyme inhibitor antibiotics and protein, for the treatment and/or prophylaxis of bacterial inflammatory processes, solid tumor; norfloxacin with albumin; antiinflammatory agents, antitumor agents
09/28/2010US7803777 conjugates of polyoxyethylene glycol with diverse therapeutic agents, e.g., peptides, lipids, glycolipids and small molecules; utility in biotechnology and medicine
09/28/2010US7803430 Coating polymer solution onto inert substrate by knife or roller application or spraying and drying, using partially hydrolyzed polyvinyl alcohol, soluble in water; then coating second composition based on polyvinylpyrrolidone, soluble in water, for second layer; quick dissolving; drug delivery
09/28/2010US7803405 Vesicle encapsulating an aqueous system of a polymer and can exist as more than one phase depending on temperature and composition
09/28/2010US7803399 Delivery system for nucleic acids
09/28/2010US7803398 Includes carrier for drug (anticancer agents; anti-sense oligonucleotide against epidermal growth factor receptor) and targeted ligand (benzamide derivative, anisamide) modifying the carrier to target the encapsulated drug to a sigma receptor over-expressed cell
09/28/2010US7803397 Polyethyleneglycol-modified lipid compounds and uses thereof
09/28/2010US7803390 Stable hydroalcoholic compositions
09/28/2010US7803386 An immunogenic conjugate comprising a synthetic homopolymer of poly- gamma -glutamic acidpolypeptide covalently linked to a carrier, where the conjugate elicits an immune response against poly- gamma -glutamic acid ( gamma PGA) polypeptide; vaccine with fewer dosages; anthrax; diptheria
09/28/2010US7803375 Reducing leakage from unwanted choroidal neovasculature by administering an anti-FasL factor to permit an effective amount to localize in the neovasculature, administering a photosensitizer to the neovasculature, and irradiating it with laser light; photodynamic therapy
09/28/2010US7803374 Targeted atherosclerosis treatment
09/28/2010US7803366 Methods and compositions that enhance bioavailability of coenzyme-Q10
09/28/2010US7803354 Cosmetic and/or dermatological use of a composition comprising at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer
09/28/2010CA2587393C Pharmaceutical manufacturing process
09/28/2010CA2480065C Injectable veterinary composition for small animals
09/28/2010CA2479640C Hfa suspension formulations containing an anticholinergic
09/28/2010CA2478515C Pharmaceutical preparation containing oxycodone and naloxone
09/28/2010CA2478411C Palatable oral suspension and method
09/28/2010CA2464152C Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
09/28/2010CA2449952C Medicinal composition
09/28/2010CA2436414C Veterinary dermatologic composition
09/28/2010CA2430366C Improved oral delivery of peptides using enzyme-cleavable membrane translocators
09/28/2010CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/28/2010CA2326821C Nucleic acid encoding hyaluronan synthase and methods of use
09/28/2010CA2286288C Monoclonal antibody recognizing the n-glycolylated-galacotose-glucose sialic acid oligosaccharide in malignant tumors and composition that contains it
09/28/2010CA2153494C Novel parasitic helminth proteins
09/27/2010CA2692917A1 Low-swelling biocompatible hydrogels
09/23/2010WO2010108077A2 Controlled release particulates containing water-insoluble drug
09/23/2010WO2010107966A1 Pharmaceutical composition comprising aliskiren
09/23/2010WO2010107831A1 Nanocarrier compositions and methods
09/23/2010WO2010107342A2 Agent and method for washing down solid dosage forms
09/23/2010WO2010107081A1 Solid preparation stably preserved in packaging
09/23/2010WO2010107040A1 Solid preparation containing npy y5 receptor antagonist
09/23/2010WO2010106981A1 Base material for spraying comprising low-molecular gelling agent
09/23/2010WO2010106936A1 Orally disintegrating tablet
09/23/2010WO2010106812A1 Pharmaceutical formulation containing improved antibody molecules
09/23/2010WO2010106700A1 Protein electrical charge regulator and polymeric micelle complex having a protein encapsulated therein
09/23/2010WO2010106571A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
09/23/2010WO2010106313A1 Improvement in solubility of drugs by means of hyaluronic acid
09/23/2010WO2010105842A2 Preparation for external application
09/23/2010WO2010105450A1 A layered double hydroxide complex inserted by carnosine and the preparation method thereof
09/23/2010WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression
09/23/2010WO2010105361A1 Oct guided tissue ablation
09/23/2010WO2010074460A3 Novel pharmaceutical composition for ameliorating side effects of a lipase inhibitor
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 1712